Job details

Research Associate, Next Generation Sequencing

Our mission is to make biology easier to engineer. Ginkgo is constructing, editing, and redesigning the living world in order to answer the globe's growing challenges in health, energy, food, materials, and more. Our bioengineers make use of an in-house automated foundry for designing and building new organisms.

Ginkgo's Next Generation Sequencing (NGS) group enables diverse synthetic biology projects by providing sequencing services to organism engineering teams. Our services include DNA and RNA sequencing using short read (Illumina) and long read (PacBio and Oxford Nanopore) platforms. We confirm synthetic constructs, genomic edits, and expression profiles of engineered organisms. We help develop the next generation of therapeutics in RNA and gene therapy.

As a Research Associate in our NGS group, you will empower Ginkgo's organism engineers with high-quality and high-throughput RNA extraction, RNA sequencing, and qPCR services. By adding your own expertise to an interdisciplinary team of bench scientists, computational biologists, data scientists, and software engineers, your role will be critical to developing world-changing methods for engineering biology.

Responsibilities

Enable the work of cell engineering by providing cutting edge NGS services across a wide range of systems including mammalian cells and tissues
Coordinate with external research organizations and animal facilities to empower Ginkgo's development of the next generation of therapeutics
Improve and perform tissue RNA extraction protocols
Improve and perform qPCR and RNA sequencing protocols
Expand your abilities and the team's capabilities by learning new skills, developing new nucleic acid extraction methods, and improving our existing offerings including qPCR and RNAseq
Maintain excellent customer service by coordinating with Ginkgo's growing mammalian program teams to process samples and return results for ground-breaking studies
Demonstrate excellence by troubleshooting issues and maintaining our high standards for quality
Be a team player by participating in general laboratory maintenance and other laboratory duties

Minimum Requirements

BS/MS in a relevant field of biological sciences and a minimum of 2+ years of experience
Experience with RNA and/or DNA extraction from animal tissues
Experience with PCR and/or qPCR
Ability to work effectively in a cross-functional team environment
Flexibility and willingness to learn in a rapidly changing, growing organization

Preferred Capabilities and Experience

Experience with DNA and RNA extraction from filamentous fungi and bacteria is a plus
Experience with qPCR assay and primer design is a plus
Experience with high-throughput automation

To learn more about Ginkgo, visit www.ginkgobioworks.com/press/ or check out some curated press below:

What is it really like to take your company public via a SPAC? One Boston biotech shares its journey (Fortune)
Ginkgo Bioworks resizes the definition of going big in biotech, raising $2.5B in a record SPAC deal that weighs in with a whopping $15B-plus valuation (Endpoints News)
Ginkgo Bioworks CEO on scaling up Covid-19 testing: 'If we try, we can win' (CNBC)
Ginkgo raises $70 million to ramp up COVID-19 testing for employers, universities (Boston Globe)
Ginkgo Bioworks Redirects Its Biotech Platform to Coronavirus (Wall Street Journal)
Ginkgo Bioworks Provides Support on Process Optimization to Moderna for COVID-19 Response (PRNewswire)
The Life Factory: Synthetic Organisms From This $1.4 Billion Startup Will Revolutionize Manufacturing (Forbes)
Synthetic Bio Pioneer Ginkgo Raises $290 Million in New Funding (Bloomberg)
Ginkgo Bioworks raises $350 million fund for biotech spinouts (Reuters)
Can This Company Convince You to Love GMOs? (The Atlantic)

We also feel that it's important to point out the obvious here – there's a serious lack of diversity in our industry, and that needs to change. Our goal is to help drive that change. Ginkgo is deeply committed to diversity, equity, and inclusion in all of its practices, especially when it comes to growing our team. Our culture promotes inclusion and embraces how rewarding it is to work with people from all walks of life.

We're developing a powerful biological engineering platform, so we must remain mindful of the many ways our technology can – and will – impact people around the world. We care about how our platform is used, and having a diverse team to build it gives us the best chance that it's something we'll be proud of as it continues to grow. Therefore, it's critical that we incorporate the diverse voices and visions of all those who play a role in the future of biology.

It is the policy of Ginkgo Bioworks to provide equal employment opportunities to all employees, employment applicants, and EOE disability/vet.

Privacy Notice
I understand that I am applying for employment with Ginkgo Bioworks and am being asked to provide information in connection with my application. I further understand that Ginkgo gathers this information through a third-party service provider and that Ginkgo may also use other service providers to assist in the application process. Ginkgo may share my information with such third-party service providers in connection with my application and for the start of employment. Ginkgo will treat my information in accordance with Ginkgo's Privacy Policy. By submitting this job application, I am acknowledging that I have reviewed and agree to Ginkgo's Privacy Policy as well as the privacy policies of the third-party service providers used by Ginkgo's associated with the application process.

Ginkgo BioWorks Glassdoor Company Review

4.2

Ginkgo BioWorks DE&I Review

4.2

CEO of Ginkgo BioWorks

Jason Kelly

Approve of CEO

By Ginkgo BioWorks

Ginkgo was founded with the mission to make biology easier to engineer. Engineering biology isn't easy. It is frustratingly, painfully difficult. It's programming without a debugger, manufacturing without CAD, and construction without cranes. At G...

9 jobs

INDUSTRY

Biotech & Pharmaceuticals

TEAM SIZE

201-500

LOCATION

Hybrid, based in Boston, MA

DATE POSTED

June 11, 2023